Author, as appears in the article.: González González NL; González Dávila E; Bugatto F; Vega-Guedes B; Pintado P; Tascón L; Villalba Martin N; Plasencia W; Megía A
Department: Medicina i Cirurgia
URV's Author/s: Megía Colet, Ana
Keywords: Pregnancy Perinatal outcomes Gestational hyperglycemia Gestational diabetes First trimester Fasting glucose Early gestational diabetes Diagnosis Covid-19 pandemic recommendations perinatal outcomes management hyperglycemia gestational hyperglycemia gestational diabetes first trimester fasting glucose early gestational diabetes diagnosis classification association
Abstract: BACKGROUND: During the COVID-19 pandemic, different non-validated tests were proposed to simplify the diagnosis of gestational diabetes (GDM). AIM: To analyse the effects of replacing the two-step approach for Early-GDM and GDM diagnosis, with a fasting plasma glucose test. MATERIAL AND METHODS: This is a cohort study consisting of 3200 pregnant women: 400 with Early-GDM, 800 with GDM and 2000 with Non-GDM diagnosed using the two-step approach. Using fasting plasma glucose for Early-GDM and GDM diagnosis, according to the recommendations of Spain, Australia, Italy and the UK during the pandemic, the rates of missed and new Early-GDM and GDM were calculated and perinatal outcomes were analysed. RESULTS: Using fasting plasma glucose in the first trimester >100 mg/dL for Early-GDM diagnosis, the rates of post-COVID missed and new Early-GDM were 79.5% and 3.2%, respectively. Using fasting plasma glucose at 24-28 weeks <84 or >92, 95 or 100 mg/dL for GDM diagnosis, the rates of missed GDM were 50.4%, 78%, 82.6% and 92.4%, respectively, and 8.6%, 5.6% and 2.3% women with Non-GDM were diagnosed with new GDM. CONCLUSION: Fasting plasma glucose is not a good test for the diagnosis of GDM either in the first trimester or at 24-28 weeks.
Thematic Areas: Zootecnia / recursos pesqueiros Saúde coletiva Química Psicología Planejamento urbano e regional / demografia Nutrition and dietetics Nutrition & dietetics Nutrição Medicina veterinaria Medicina iii Medicina ii Medicina i Interdisciplinar Food science Farmacia Engenharias iv Engenharias ii Enfermagem Educação física Economia Ciências biológicas iii Ciências biológicas ii Ciências biológicas i Ciências agrárias i Ciência de alimentos Biotecnología
licence for use: https://creativecommons.org/licenses/by/3.0/es/
Author's mail: ana.megia@urv.cat
Author identifier: 0000-0002-5101-9452
Record's date: 2024-09-07
Papper version: info:eu-repo/semantics/publishedVersion
Link to the original source: https://www.mdpi.com/2072-6643/14/16/3432
Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
Papper original source: Nutrients. 14 (16):
APA: González González NL; González Dávila E; Bugatto F; Vega-Guedes B; Pintado P; Tascón L; Villalba Martin N; Plasencia W; Megía A (2022). Fasting Glucose for the Diagnosis of Gestational Diabetes Mellitus (GDM) during the COVID-19 Pandemic. Nutrients, 14(16), -. DOI: 10.3390/nu14163432
Article's DOI: 10.3390/nu14163432
Entity: Universitat Rovira i Virgili
Journal publication year: 2022
Publication Type: Journal Publications
Repositori URV